When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Montelukast - Wikipedia

   en.wikipedia.org/wiki/Montelukast

   Singulair was covered by US Patent No. 5,565,473 [27] which expired on 3 August 2012. [28] The same day, the FDA approved several generic versions of montelukast. [29] The United States Patent and Trademark Office launched a reexamination of the patent covering Singulair on May 2009. The decision was driven by the discovery of references that ...

3. Exclusive-US FDA finds widely used asthma drug impacts ... - AOL

   www.aol.com/news/exclusive-us-fda-finds-widely...

   By 2019, the FDA tallied 82 suicides linked to Singulair and its generic versions reported to its adverse-event database since 1998. At least 31 of those reports involved someone age 19 or younger.

4. Popular asthma drug Singulair could be linked to mental ... - AOL

   www.aol.com/popular-asthma-drug-singulair-could...

   Singulair, originally sold by Merck & Co., is a prescription drug that was launched in 1998 and is used to prevent and treat symptoms of asthma and allergies, according to the Cleveland Clinic, by ...

5. Ignore the Noise With This Pharma - AOL

   www.aol.com/news/2012-10-29-ignore-the-noise...

   For premium support please call: 800-290-4726 more ways to reach us

6. Budesonide/formoterol - Wikipedia

   en.wikipedia.org/wiki/Budesonide/formoterol

   Budesonide/formoterol, sold under the brand name Symbicort among others, is a fixed-dose combination medication used in the management of asthma or chronic obstructive pulmonary disease (COPD). [2]

7. Generic drug - Wikipedia

   en.wikipedia.org/wiki/Generic_drug

   [23] also the according to market research community the Global Generic Drugs Market was evaluated US$465.96 million in 2021 and is expected to rise with a CAGR of 5.5% from 2022- 2028 during the forecast period. [24] In the United Kingdom, generic drug pricing is controlled by the government's reimbursement rate.